Press Releases Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Real-time Estimate Cboe BZX Other stock markets 01:30:23 2024-05-09 pm EDT			5-day change	1st Jan Change
3.315 ^USD	+2.95%		+1.38%	+119.54%

Apr. 17	RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	MT
Apr. 10	Nuvation Bio Closes Acquisition of AnHeart Therapeutics	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology Annual Meeting	Apr. 25	AQ
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	Apr. 24	BU
Nuvation Bio : Acquisition/Asset Disposal - Form 8-K	Apr. 10	PU
Nuvation Bio Completes Acquisition of AnHeart Therapeutics	Apr. 10	BU
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer	Mar. 28	BU
Thinking about buying stock in BigBear.ai, Bitfarms, Paysign, Nuvation Bio, or One Group Hospitality?	Mar. 27	PR
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction	Mar. 25	BU
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors	Mar. 14	BU
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	Feb. 29	BU
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors	Jan. 08	BU
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors	Jan. 08	BU
Nuvation Bio Announces Departure of Chief Financial Officer	Nov. 13	BU
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update	Nov. 02	BU
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update	23-08-03	BU
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board	23-06-01	BU
NUVATION BIO INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-05-16	AQ
NUVATION BIO INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-05-04	AQ
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update	23-05-04	BU
NUVATION BIO INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-15	AQ
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update	23-03-15	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Press Releases

Filters